12个月医疗费用和利用率:莱姆病与对照组
基于美国商业保险索赔数据,比较莱姆病患者与对照组的12个月医疗费用和利用率。

基本信息
资源简介
12个月医疗费用和利用率:莱姆病与对照组
【数据集背景】
本数据集源站标题为《12-month health care costs and utilization, Lyme disease and control groups.》。配套论文《Health Care Costs, Utilization and Patterns of Care following Lyme Disease》发表于 PLOS ONE(2015),DOI:10.1371/journal.pone.0116767。源站首次发布:2015-02-04。
【数据内容】
源站原始描述:*** statistically significant at p* Lyme disease sample includes only those persons with a test order and antibiotic treatment within 30 days of the test order, a diagnosis and antibiotic treatment within 30 days of the diagnosis, or a diagnosis, test order and antibiotic treatment within 30 days. The Lyme disease sample includes only those with 18 consecutive months of enrollment, including a 6-month “clean period” of enrollment prior to Lyme disease episode in which they were neither diagnosed…
【数据结构与技术规格】
文件数 1 个,合计 9.73 KB。Table_2.xls:application/vnd.ms-excel,9.73 KB。数据集 DOI:10.1371/journal.pone.0116767.t002。
【主题与分类】
源站学科分类:Biological Sciences、Science Policy。主题标签:health care costs、health insurance plans、Lyme disease exposure.ResultsLyme disease、United States、ci、Lyme disease、Lyme Disease BackgroundLyme disease、PTLDS。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://plos.figshare.com/articles/dataset/_12_month_health_care_costs_and_utilization_Lyme_disease_and_control_groups_/1301347
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:R. Adrion, Emily; Aucott, John; W. Lemke, Klaus; P. Weiner, Jonathan (2015). 12-month health care costs and utilization, Lyme disease and control groups.. PLOS ONE. Dataset
【使用注意】
· 源站最后修改于 2023-06-01,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:12-month health care costs and utilization, Lyme disease and control groups.
- DOI:10.1371/journal.pone.0116767.t002
- 发布日期:2015-02-04
- 文件数:1 个
- 文件总体积:9.73 KB
- 源站页面:https://plos.figshare.com/articles/dataset/_12_month_health_care_costs_and_utilization_Lyme_disease_and_control_groups_/1301347
命令行下载
curl -L -o "Table_2.xls" "https://ndownloader.figshare.com/files/1880498"
文件清单
Table_2.xls(9.73 KB)
文件总体积 9.73 KB(源站 API 实测)。
数据说明
*** statistically significant at p* Lyme disease sample includes only those persons with a test order and antibiotic treatment within 30 days of the test order, a diagnosis and antibiotic treatment within 30 days of the diagnosis, or a diagnosis, test order and antibiotic treatment within 30 days. The Lyme disease sample includes only those with 18 consecutive months of enrollment, including a 6-month “clean period” of enrollment prior to Lyme disease episode in which they were neither diagnosed with nor tested for Lyme disease.
† Lyme disease and control samples are restricted to persons under 65 years of age, in commercial health insurance plans.
‡ Controls were matched to Lyme disease cases on age, sex, region, payer and enrollment year. Control group includes only those with 18 consecutive months of enrollment in a commercial health insurance plan. Control group was restricted to persons with outpatient costs greater than $0.
§ Medicine includes acupuncture, home health, home infusion and other special services, procedures and reports.
|| Adjusted impact calculations based on GLM regression analysis using the Huber/White sandwich estimator of variance and adjusting for year, region, age, and sex, and controlling for 44 high-cost conditions
¶ Adjusted ratio calculations for outpatient and emergency visits are based on negative binomial regression analysis using the Huber/White sandwich estimator of variance and adjusting for year, region, age, and sex, and controlling for 44 high-cost conditions.
12-month health care costs and utilization, Lyme disease and control groups.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.1371/journal.pone.0116767.t002(source: https://plos.figshare.com/articles/dataset/_12_month_health_care_costs_and_utilization_Lyme_disease_and_control_groups_/1301347)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




